Musculoskeletal translational research collaboration
What is the UK MSK TRC?
The UK Musculoskeletal Translational Research Collaboration (UK MSK TRC) is a joint initiative between Versus Arthritis and the National Institute for Health Research (NIHR) for early phase translational research. The collaboration brings together our previous investment in Experimental Arthritis and Osteoarthritis Treatment Centres with the NIHR infrastructure through their relevant Biomedical Research Centres.
By bringing together national expertise in musculoskeletal translational research, the collaboration aims to create a UK-wide ambition and focus to drive cutting edge translational research and will move us closer towards a world free from pain, fatigue and isolation of arthritis. The UK MSK TRC will also provide industry with streamlined access to world leading academic clinicians and scientists with expertise in conditions including:
- connective tissue diseases
- inflammatory arthritis
In addition, by providing a network of expertise and a collaboration in which to undertake clinical studies, we hope that this collaboration will stimulate industry activity in musculoskeletal research and will play a role in increasing the investment in musculoskeletal research to levels that equate the scale of the impact of arthritis.
The UK MSK TRC works collaboratively with all sectors of the health and care ecosystem including the life sciences industry, charities and other funders to further research in musculoskeletal disorders and to help develop new diagnostics and treatments. Areas of unmet need are regularly reviewed to determine emerging topics that could become a focus for the group.
Patient and public involvement and engagement is a central theme of the TRC approach, through a strong relationship people with arthritis via both Versus Arthritis and the NIHR.
“By working together, we can accelerate the development of new treatments, devices and diagnostics to tackle complex areas of unmet healthcare needs.”
UK MSK TRC partner organisations
|Professor Costantino Pitzalis||Barts Health NHS Trust; Queen Mary University of London|
|Professor David Isenberg||University College London Hospitals NHS Foundation Trust; Royal Free London NHS Foundation Trust; University College London|
|Professor Peter C Taylor||Oxford University Hospitals NHS Trust; University of Oxford|
|Professor John Isaacs||The Newcastle upon Tyne Hospitals NHS Foundation Trust; Newcastle University|
|Professor Ian Bruce||Manchester Academic Health Science Centre|
|Professor Chris Buckley||The University of Birmingham; Birmingham/Sandwell/Dudley Hospitals|
|Dr Natasha Jordan||Cambridge University Hospitals NHS Foundation Trust; University of Cambridge|
|Dr Matthew Pickering||Imperial College London; Imperial College Healthcare NHS Trust|
|Professor Andrew Cope||King's Health Partners Academic Health Science Centre|
|Professor David Walsh||Nottingham University Hospitals NHS Trust; University of Nottingham|
|Professor Maya Buch||University of Leeds; Leeds Teaching Hospitals NHS Trust|
|Professor Chris Edwards||University of Southampton; University Hospital Southampton NHS Foundation Trust|
|Professor Michael Beresford||University of Liverpool; EATC4children|
|Professor Athimalaipet Ramanan||Bristol Royal Hospital For Children; EATC4Children|
|Professor Ernest Choy||Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre (CREATE)|
|Professor Iain McInnes||University of Glasgow; Research into Inflammatory Arthritis Centre Versus Arthritis (RACE)|
For more details, or to find out how you can collaborate with us, please contact Keith Pugh at email@example.com.